| Prev Close: | 5.16 |
|---|---|
| Open: | 5.13 |
| Bid: | 5.09 x 800 |
| Ask: | 5.10 x 200 |
| 1y Target Est: | 5.24 |
| Beta: | 1.02 |
| Next Earnings Date: | 29-Jul-13 |
| Day's Range: | 5.09 - 5.14 |
|---|---|
| 52wk Range: | 3.45 - 6.15 |
| Volume: | 35,312 |
| Avg Vol (3m): | 165,532 |
| Market Cap: | 153.32M |
| P/E (ttm): | 82.26 |
| EPS (ttm): | 0.06 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- HARVARD BIOSCIENCE INC FinancialsEDGAR Online Financials(Fri May 17)
- Finding Investment Opportunities in Quality Growth Health Care Companies That the Rest of the Market is OverlookingWall Street Transcript(Fri May 17)
- HARVARD BIOSCIENCE INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Wed May 15)
- Harvard Bioscience CEO Graziano will retireAP(Wed May 15)
- Harvard Bioscience Announces Retirement of CEO and Appointment of Interim CEOGlobeNewswire(Wed May 15)
- HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri May 10)
- Short On Oculus: Wound Care Company Has Left Dirty Scarsat Seeking Alpha(Tue May 7)
- HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExEDGAR Online(Tue May 7)
- Q1 2013 Harvard Bioscience, Inc. Earnings Release - Before Market OpenCCBN(Thu May 2)
- HBIO Reports First Quarter 2013 ResultsGlobeNewswire(Thu May 2)
- HBIO Affirms Plan to Spin-Off Harvard Apparatus Regenerative Technology, Inc. and Announces Its Intended Path ForwardGlobeNewswire(Wed May 1)
- Webcast Now Available of Press Conference Discussing Landmark Surgery Involving Harvard Bioscience's Synthetic Trachea Scaffold and "InBreath" BioreactorGlobeNewswire(Tue Apr 30)
- Photo Release -- Harvard Apparatus Regenerative Technology's "InBreath" Scaffold and Bioreactor Used in First U.S. Transplant of a Regenerated TracheaGlobeNewswire(Tue Apr 30)
- Harvard Bioscience to Participate in Press Conference Today to Discuss Landmark SurgeryGlobeNewswire(Tue Apr 30)
- Harvard Bioscience, Inc. Schedules First Quarter 2013 Conference Call for May 2, 2013GlobeNewswire(Fri Apr 26)
Press Releases
- Harvard Bioscience Announces Retirement of CEO and Appointment of Interim CEOGlobeNewswire(Wed May 15)
- HBIO Reports First Quarter 2013 ResultsGlobeNewswire(Thu May 2)
Must Read
- News Corp. board approves poison pill, $500 million stock buyback before splitThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Top 10 items found during 2012 coastal cleanupThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- TSX dragged down by falling gold stocks, but lifted on possible Valeant dealThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- MTS to sell Allstream to Egyptian investment group, focus on Manitoba marketThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- National Bank considering new acquisitions in Canadian wealth managementThe Canadian Press(1969-12-31T18:59:59GMT-05:00)